BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20865267)

  • 1. Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Küsters B; van Dijk MR; Groenen PJ; Wesseling P; Blokx WA
    Acta Neuropathol; 2010 Dec; 120(6):755-64. PubMed ID: 20865267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary leptomeningeal melanocytic neoplasms: A clinicopathologic, immunohistochemical, and molecular study of 12 cases.
    Lv JJ; Yao QL; Jiang XB; Ren M; Cai X; Dai B; Kong YY
    Hum Pathol; 2024 Jun; 148():32-40. PubMed ID: 38670237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound blue nevus: A misleading pigmented melanocytic tumor.
    Baklouti M; Sellami K; Elleuch N; Rekik M; Saguem I; Kamoun C; Gouiaa N; Ben Messaoud H; Karray F; Abdelmoula M; Sellami T; Turki H
    Clin Case Rep; 2022 Jan; 10(1):e05311. PubMed ID: 35079400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAQ-mutated primary subcutaneous blue melanoma arising in naevus of Ota presenting as a skin-coloured forehead mass.
    Santiago S; Roy SF; Tran TT; Bosenberg M; Weston GK
    Pathology; 2024 Apr; 56(3):426-428. PubMed ID: 37872018
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant Transformation and Leptomeningeal Melanomatosis in a Primary Meningeal Melanocytoma: A Case Report and Review of Literature.
    Nakase K; Matsuda R; Okamoto T; Nakagawa I; Takeda M; Sakata K; Nakase H
    NMC Case Rep J; 2023; 10():315-320. PubMed ID: 38076394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non psammomatous melanocytic schwannoma presenting as a subcutaneous nodule: A rare presentation of a rare lesion.
    Gulati HK; Joshi AR; Anand M; Deshmukh SD
    Asian J Neurosurg; 2016; 11(3):317-8. PubMed ID: 27366278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkpoint inhibitors and radiotherapy in refractory malignant melanocytic schwannoma with Carney complex: first evidence of efficacy.
    Bajpai J; Kapoor A; Jalali R; Gounder MM
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34049890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanotic schwannoma of maxilla.
    Jana U; Sana AK
    Indian J Otolaryngol Head Neck Surg; 2002 Oct; 54(4):303-4. PubMed ID: 23119918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial Soft Tissue Lesions in Children.
    Beck CM; Onyekweli T; Ettinger RE; Boos MD
    Oral Maxillofac Surg Clin North Am; 2024 May; ():. PubMed ID: 38724424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Melanotic Deposits in Breast.
    Proc R Soc Med; 1930 Feb; 23(4):552-3. PubMed ID: 19987411
    [No Abstract]   [Full Text] [Related]  

  • 11. Case of Melanotic Nævo-carcinoma (previously shown).
    Pernet G
    Proc R Soc Med; 1919; 12(Dermatol Sect):42-3. PubMed ID: 19980363
    [No Abstract]   [Full Text] [Related]  

  • 12. Microscopic Examination of a Case of Morbus Brightii, in Connection with Melanotic Cancer.
    Wythes JH
    Med Exam (Phila); 1854 Feb; 10(110):72-76. PubMed ID: 38121836
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
    Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA
    Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
    Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
    Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: MRI and CT imaging features of a melanocytic tumour affecting a cervical vertebra in an adult dog, and review of differential diagnosis for T1W-hyperintense lesions.
    Michaelidou EE; Kaczmarska A; Gutierrez-Quintana R; Morris J; Hammond G; Cloquell A
    Front Vet Sci; 2024; 11():1334813. PubMed ID: 38655532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Melanotic Nerve Sheath Tumors: A Review of Clinicopathologic and Molecular Characteristics.
    Hammad RM
    J Microsc Ultrastruct; 2023; 11(3):125-129. PubMed ID: 38025185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical primary malignant melanoma originating in the spinal canal: A case report and literature review.
    Zeng Y; Zhang Y; Zhang J; Jian W; Li R; Fu Q
    Oncol Lett; 2023 Oct; 26(4):433. PubMed ID: 37664668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutations.
    Terry M; Wakeman K; Williams BJ; Miller DM; Sak M; Abdullaev Z; Pacheco MC; Aldape K; Lehman NL
    Free Neuropathol; 2022 Jan; 3():. PubMed ID: 37284154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic spinal psammomatous malignant melanotic nerve sheath tumor: A case report and literature review.
    Bonomo G; Gans A; Mazzapicchi E; Rubiu E; Alimonti P; Eoli M; Paterra R; Pollo B; Iess G; Restelli F; Falco J; Acerbi F; Schiariti MP; Ferroli P; Broggi M
    Front Oncol; 2023; 13():1100532. PubMed ID: 36910634
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.